Atypical hemolytic uremic syndrome: Unique clinical presentation linked to rare CFHR5 mutation

Lignende værker

• Complement Factor H and Complement Factor H-Related Protein 5 Mutations Associated with Atypical Hemolytic Uremic Syndrome in a Systemic Lupus Erythematosus Patient: Efficacy of Eculizumab
  af: Sibel ERSAN, et al.
  Udgivet: (2019-01-01)
• Pediatric Atypical Hemolytic Uremic Syndrome Advances
  af: Rupesh Raina, et al.
  Udgivet: (2021-12-01)
• Application of eculizumab, a terminal complement inhibitor, in the management of atypical hemolytic uremic syndrome in a 14-month-old Chinese pediatric patient: a case report
  af: Xin Wei, et al.
  Udgivet: (2024-07-01)
• Pregnancy-Associated Atypical Hemolytic Uremic Syndrome: A Case Report with <i>MCP</i> Gene Mutation and Successful Eculizumab Treatment
  af: Alex Domínguez-Vargas, et al.
  Udgivet: (2024-01-01)
• Eculizumab is efficacious and safe in pediatric patients with various forms of hemolytic uremic syndrome: a retrospective clinical experience of a tertiary center
  af: Naama Lax, et al.
  Udgivet: (2025-04-01)